Novo Nordisk CFO On Metsera, Hims And Lilly, And Why 'Hyper Growth' Has Stalled

Published 6 days ago Neutral
Novo Nordisk CFO On Metsera, Hims And Lilly, And Why 'Hyper Growth' Has Stalled
Auto

Related Stocks

NOVO-B.CO Novo Nordisk A/... PFE.BA Pfizer Inc
Novo Nordisk stock skidded early Wednesday after the Wegovy and Ozempic maker cut its sales outlook for the third time this year.

Continue Reading

View Comments

More News

Saudi Arabia Plastic Recycling Market Analysis Report 2025-2034: Increasing Demand for Polyethylene Terephthalate (PET) to Aid Growth

5 hours ago Positive

Saudi Arabia Pet Care Analysis, Forecast Trends and Outlook Report 2025-2034: Market to Grow at a CAGR of 7.2%, Fueled by Growing Birds Segment and Increasing Affordability of Pet Care Products

6 hours ago Positive

Castle Biosciences to Present at the Piper Sandler 37th Annual Healthcare Conference

6 hours ago Neutral

Ripple CTO Explains Bitcoin's Use in Payments Amid Price Potential: Details

7 hours ago Neutral

-15,456,495,096 Shiba Inu (SHIB) in 24 Hours: Not Enough?

7 hours ago Neutral